Literature DB >> 6717055

Coronary revascularization in the presence of ascending aortic calcification: use of an internal mammary artery-saphenous vein composite graft.

D A Murphy, C R Hatcher.   

Abstract

Complications arising from manipulation of the diseased ascending aorta constitute a significant portion of the morbidity and mortality of coronary revascularization. A case is described in which coronary revascularization was achieved by extension of the left internal mammary artery with a segment of reversed saphenous vein. The major advantage of this technique is that it obviates any instrumentation of the aorta or great vessels.

Entities:  

Mesh:

Year:  1984        PMID: 6717055

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  5 in total

1.  Coronary artery bypass grafting for patients with an atherosclerotic ascending aorta.

Authors:  H Ogino; Y Ueda; T Tahata; T Sugita; J Nishizawa; K Matsuyama; S Yoshimura; T Yoshioka; Y Tokuda
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-04

2.  Coronary revascularization in a calcified ascending aorta: using the right gastroepiploic artery.

Authors:  W Ting; P M Scholz; A J Spotnitz
Journal:  Tex Heart Inst J       Date:  1992

3.  An evaluation of coronary artery bypass grafting without aortic cross-clamping due to severely atherosclerotic ascending aorta.

Authors:  Hideyuki Fumoto; Ryuzo Sakata; Yoshihiro Nakayama; Masashi Ura; Yoshio Arai
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-02

4.  A no-touch technique for calcified ascending aorta during coronary artery surgery.

Authors:  B Akpinar; M Güden; I Sanisoğlu; C Konuralp; O Yilmaz; B Sönmez
Journal:  Tex Heart Inst J       Date:  1998

5.  Comparison of Radial Artery and Saphenous Vein Composite Y Grafts during Off-pump Coronary Artery Bypass.

Authors:  Jin-Hong Wi; Hyun-Chel Joo; Young-Nam Youn; Suk-Won Song; Tae Hoon Kim; Kyung-Jong Yoo
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2013-08-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.